Livostin Eye Drops
|
$22.00 NZD
|
Recently viewed products:   |
Levocabastine is a potent, fast-acting and highly selective histamine H 1-antagonist with a sustained duration of action.
Within 10 to 15 minutes of topical application to the eyes, levocabastine inhibits: itching, redness and chemosis induced by conjunctival provocation with histamine; itching, redness, chemosis, eyelid swelling, and tearing induced by conjunctival provocation with allergens; and itching and redness induced by conjunctival provocation with compound 48/80.
Your doctor may have suggested this medication for conditions other than the ones listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.
Indications: The symptomatic management of seasonal allergic conjunctivitis.
Contraindications: In patients with hypersensitivity to any of the ingredients.
Warnings: Children: Levocabastine is not recommended for use in children under the age of 12 years except on the advice of a physician. Clinical experience in children under 5 years of age is limited with ocular levocabastine.
Precautions: As with all ophthalmic preparations containing benzalkonium chloride, patients are advised not to wear soft (hydrophilic) contact lenses while under treatment with levocabastine eye drops.
Pregnancy and Lactation: There are no clinical trials on the use of levocabastine eye drops in pregnant or nursing women; therefore, levocabastine eye drops should not be used during pregnancy, except if the potential benefit justifies the potential risk to the fetus.
Geriatrics: The safety and efficacy of topical levocabastine have not been established in patients greater than 65 years of age.
Adverse Effects: The most frequent side effect encountered with levocabastine eye drops is eye irritation. Most side effects are transient and rarely necessitate discontinuation of therapy.
Dosage: Adults and children (12 to 65 years old): 1 drop (15 µg/drop) instilled in each eye, 2 times daily. The dose may be increased to 1 drop 3 to 4 times daily.
It is not useful to continue the treatment for more than 3 days if no improvement is seen. There are no clinical studies to support continuous treatment durations of greater than 16 weeks.
As levocabastine eye drops are available as a microsuspension, the bottle should be shaken before each application. Levocabastine eye drops should be used within 1 month of the first opening of the bottle. Patients should be instructed to take appropriate measures to avoid contamination.
Within 10 to 15 minutes of topical application to the eyes, levocabastine inhibits: itching, redness and chemosis induced by conjunctival provocation with histamine; itching, redness, chemosis, eyelid swelling, and tearing induced by conjunctival provocation with allergens; and itching and redness induced by conjunctival provocation with compound 48/80.
How does this medication work? What will it do for me?
Levocabastine belongs to the class of medications called antihistamines. Levocabastine eye drops are used to relieve irritation, redness, and itching of the eye associated with allergies. It works by blocking the actions of a chemical called histamine. This medication will start to work to relieve allergy symptoms within 10 to 15 minutes of being used.Your doctor may have suggested this medication for conditions other than the ones listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.
What form(s) does this medication come in?
Each mL of white, sterile ophthalmic microsuspension contains levocabastine HCl 0.5 mg. Nonmedicinal ingredients: benzalkonium chloride 0.15 mg as preservative, disodium edetate, disodium phosphate, hypromellose, monosodium phosphate, polysorbate 80, propylene glycol, and water.Indications: The symptomatic management of seasonal allergic conjunctivitis.
Contraindications: In patients with hypersensitivity to any of the ingredients.
Warnings: Children: Levocabastine is not recommended for use in children under the age of 12 years except on the advice of a physician. Clinical experience in children under 5 years of age is limited with ocular levocabastine.
Precautions: As with all ophthalmic preparations containing benzalkonium chloride, patients are advised not to wear soft (hydrophilic) contact lenses while under treatment with levocabastine eye drops.
Pregnancy and Lactation: There are no clinical trials on the use of levocabastine eye drops in pregnant or nursing women; therefore, levocabastine eye drops should not be used during pregnancy, except if the potential benefit justifies the potential risk to the fetus.
Geriatrics: The safety and efficacy of topical levocabastine have not been established in patients greater than 65 years of age.
Adverse Effects: The most frequent side effect encountered with levocabastine eye drops is eye irritation. Most side effects are transient and rarely necessitate discontinuation of therapy.
Dosage: Adults and children (12 to 65 years old): 1 drop (15 µg/drop) instilled in each eye, 2 times daily. The dose may be increased to 1 drop 3 to 4 times daily.
It is not useful to continue the treatment for more than 3 days if no improvement is seen. There are no clinical studies to support continuous treatment durations of greater than 16 weeks.
As levocabastine eye drops are available as a microsuspension, the bottle should be shaken before each application. Levocabastine eye drops should be used within 1 month of the first opening of the bottle. Patients should be instructed to take appropriate measures to avoid contamination.